H2AZ1 and hepatocellular carcinoma: The Kaplan-Meier survival curves of patients with HCC indicated that the 5-year overall survival rate of patients with high H2A.Z.1 expression was significantly lower than that of patients with low H2A.Z.1 expression (P = 0.0466; Figure 2B).